Inhibitory effect of BCG cell-wall skeletons (BCG-CWS) emulsified in squalane on tumor growth and metastasis in mice

Archives of Pharmacal Research

Volumn 25, Issue 4, 2002, Pages 522-527

  Yung, Choon Yoo ^a   Hata, Katsusuke ^b   Kyung, Bok Lee ^a   Azuma, Ichiro ^b,c  

^a Konyang University   (South Korea)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HAKODATE NATIONAL COLLEGE OF TECHNOLOGY   (Japan)

Author keywords

Antitumor effect; bcg CWS; Squalane; Tumor metastasis

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; SQUALANE; SQUALENE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; CELL WALL; CHEMISTRY; DOSE RESPONSE; EMULSION; EXPERIMENTAL MELANOMA; LUNG TUMOR; METASTASIS; MOUSE; MYCOBACTERIUM BOVIS;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL WALL; DOSE-RESPONSE RELATIONSHIP, DRUG; EMULSIONS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; SQUALENE; TUMOR CELLS, CULTURED;

EID: 0036690228     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/bf02976612     Document Type: Article

References (21)

1. Azuma, I., Kishimoto, S., Yamamura, Y., and Petit, J.F., Adjuvanticity of mycobacterial cell walls. Jpn. J. Microbiol., 15, 193-197 (1971).
2. Azuma, I., Ribi, E.E., Meyer, T.J., and Zber, B., Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3. J. Natl. Cancer Inst., 52, 95-101 (1974).
3. Azuma, I. and Yamamura, Y., Immunotherapy of cancer with BCG cell-wall skeleton and related materials. Gann Monogr. Cancer Res., 24, 121-141 (1979).
4. Bingham, E., Stemmer, K.L., and Falk, H.L., The effects of repeated injections of certain adjuvants on chemical carcinogenesis. Ann. Allergy, 25, 684-690 (1967).
5. Fidler, I.J., Selection of successive tumour lines for metastasis. Nat. New Biol., 242, 148-149 (1973).
6. Freund, J., The mode of action of immunological adjuvants. Adv. Tuberc. Res., 7, 130-148 (1956).
7. Han, M.J., Park, H.Y., and Kim, D.H., Pretective effects of Bifidobacterium spp. on experimental colon carcinigenesis with 1,2-dimethylhydrazine. J. Microbiol. Biotechnol., 9, 368-370 (1999).
8. Hayashi, A., Interferon-g as a marker for the effective cancer immunotherapy with BCG-cell wall skeleton. Proc. Japan Acad,. 70, 205-209 (1994).
9. Hayashi, A., and Noda, A., Does the cell wall skeleton from Bacille Calmette-Guerin directly induce interferon-g, independent of interleukin-12? Jpn. J. Clin. Oncol., 26, 124-127 (1996).
10. Hirao, F., Nishikawa, H., Yasaki, S., Ogura, T., Azuma, I., Taniyama, T., Yoshimoto, T., Kishimoto, S., and Yamamura, Y., Effect of oil-attached BCG cell-wall skeleton and thymectomy on the incidence of lung cancer and amyloidosis induced by chemical carcinogens in rabbits. Gann, 69, 453-459 (1978).
11. Kang, T.Y., Park, S.H., and Choe, T.B., Immunostimulating effects of cell wall components isolated from Lactobacillus plantarum. J. Microbiol. Biotechnol., 4, 195-199 (1994).
12. Kuwamura, S., Studies on the relationship between the induction of primary hepatic carcinoma by 3′-methyl-4-dimethylaminoazobenzene and cell-mediated immunity in hosts. J. Osaka City Med. Cent,. 26, 145-157 (1977).
13. Matsumoto, M., Seya, T., Kikkawa, S., Tsuji, S., Shida, K., Nomura, M., Kurita-Taniguchi, M., Ohigashi H., Yokouchi, H., Takami, H., Hayashi, A., Azuma, I., Masaoka, T., Kodama, K., and Toyoshima, K., Interferon gamma-producing activity in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton. Int. Immunopharmacol., 1(8), 1559-1569 (2001).
14. Ogura, T., Namba, M., Hirao, F., Yamawaki, M., Azuma, I., and Yamamura Y., Effect of BCG cell-wall skeleton on metastasis of syngeneic tumor in rats, with special reference to lymphocyte trapping. Gann, 69, 311-315 (1978).
15. Okuyama, H. and Morikawa, K., Histological study on adjuvanticity of BCG-cell wall: Comparison of adjuvanticity between oil-in-water and water-in-oil forms. GANN Monogr. Cancer Res., 21, 87-91 (1978).
16. Tokuzen, R., Okabe, M., Nakahara, W., Azuma, I., and Yamamura, Y., Effect of Nocardia and Mycobacterium cellwall skeletons on autochthonous tumor grafts. Gann, 66, 433-435 (1975).
17. Whitehouse, M.W., Orr, K.J., Beck, F.W., and Pearson, C., Freund's Adjuvants: Relationship of arthritogenicity and adjuvanticity in rats to vehicle composition. Immunology, 27, 311-330 (1974).
18. Yoo, Y.C., Saiki, I., Sato, K., and Azuma, I., MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumors in mice. Vaccine, 12, 175-180 (1994).
19. Yoo, Y.C., Watanabe, S., Watanabe, R., Hata, K., Shimazaki, K., and Azuma, I., Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn. J. Cancer Res., 88, 184-19 (1997).
20. Yoo, Y.C., Park, S.Y., Lee, K.B., and Azuma, I., MDP-Lys(L18), a synthetic muramyl dipeptide derivative, enhances antitumor activity of an inactivated tumor vaccine. J. Microbiol. Biotechnol., 10, 399-404 (2000).
21. Yoshimoto, T., Azuma, I., Sakatani, M., Nishikawa, H., Ogura, T., Hirao, F., and Yamamura, Y., Effect of oil-attached BCG cell-wall skeleton on the induction of pleural fibrosarcoma in mice. Gann, 67, 441-445 (1976).